Malignant Pleural Mesothelioma
📧 Sign up to get email alerts when something new happens for Malignant Pleural Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma [Phase 1]
Clinical trial update for Phase 1 study of Nivolumab plus chemotherapy followed by surgery in malignant pleural mesothelioma; the trial is c…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study of NX-1607 in Adults With Advanced Malignancies [Phase 1]
A Phase 1 study evaluating NX-1607 in adults with advanced malignancies is actively recruiting across multiple tumor types, including ovaria…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Immune Microenvironment and Gene Expression Profiling in Mesothelioma
A clinical trial update describes a study evaluating the immune microenvironment and gene expression profiling in mesothelioma, focusing on …
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Gavo-cel (TC-210), a mesothelin-targeted therapy, in patients with advanced mesothelin-expressing cancer…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access
The SPECTAlung thoracic-tumor screening program has completed, documenting screening patients with lung cancer, malignant pleural mesothelio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma [Phase 2]
Phase 2 clinical trial evaluating pleurectomy/decortication with neoadjuvant/adjuvant chemotherapy and pleural-intensity modulated radiation…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study [Phase 1, Phase 2]
This study investigates NECIM, a Phase 1/2 feasibility trial of neoadjuvant chemotherapy plus immunotherapy for selected inoperable pleural …
-
FDA approval · 2025-08-06FDA Approved: PEMETREXED — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for pemetrexed by Accord Healthcare Inc., enabling the generic version to be marketed under approved…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: CT-95 in Advanced Cancers Associated With Mesothelin Expression [Phase 1]
Phase 1 trial CT-95 for mesothelin-expressing tumors is currently recruiting across multiple indications, including epithelial ovarian cance…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma [Phase 1]
This is a Phase 1 clinical trial evaluating a mesothelin-targeted CAR T-cell therapy in malignant pleural mesothelioma. The study status is …
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy with or without surgery and chemoradiotherapy in malignant pleural mesothelioma; …
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma
This clinical trial update describes the SMART trial evaluating surgery after radiation therapy for resectable malignant pleural mesotheliom…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: CART-meso in Mesothelin Expressing Cancers [Phase 1]
Phase 1 update on CART-meso, a mesothelin-targeted CAR T-cell therapy, tested in mesothelin-expressing cancers including metastatic pancreat…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma [Phase 2]
This is an update on a Phase 2 clinical trial evaluating neoadjuvant immune checkpoint blockade for patients with resectable malignant pleur…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma [Phase 1]
Phase 1 trial of Poly-ICLC (Hiltonol) vaccine in malignant pleural mesothelioma has been completed.
-
FDA approval · 2025-06-18FDA Approved: AXTLE — Supplemental Application (Avyxa Pharma, LLC)
FDA approved a supplemental application for AXTLE (pemetrexed) submitted by Avyxa Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: APG-2449 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial of APG-2449 in patients with advanced solid tumors is currently recruiting, including non-small cell lung cancer, esophageal…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma [Phase 3]
Phase 3 BEAT-meso trial evaluating bevacizumab and atezolizumab in malignant pleural mesothelioma has completed.
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma [Phase 2]
Phase 2 trial evaluating first-line sintilimab in combination with anlotinib and platinum doublet chemotherapy for malignant pleural mesothe…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma [Phase 2]
A Phase 2 clinical trial studying pembrolizumab plus chemotherapy with lenvatinib for malignant pleural mesothelioma is currently recruiting…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma [Phase 3]
Phase 3 trial update reports efficacy and safety results for a combination of rAd-IFN with celecoxib and gemcitabine in malignant pleural me…
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: Autologous Dendritic Cell Vaccination in Mesothelioma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating an autologous dendritic cell vaccine for malignant pleural mesothelioma has completed enrollment.
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: dENdritic Cell Therapy Combined With SURgEry in Mesothelioma [Phase 1]
Phase 1 trial of dendritic cell therapy combined with surgery for malignant pleural mesothelioma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Hemithoracic Arc Radiotherapy Post Pleural Decortication [NA]
A clinical trial evaluating hemithoracic arc radiotherapy after pleural decortication for malignant pleural mesothelioma is currently recrui…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
This clinical trial update announces ongoing recruitment for the TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO study led by Un…